TE_38265
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | LTR7C |
---|---|
TE superfamily | ERV1 |
TE class | LTR |
Gene | PLCXD1 |
Class | Chimeric |
Coding | Non-coding, Other |
Tumor-specific score | 213.02 |
Counts of samples | TCGA_tumor:188; TCGA_normal:0; GTEx:0 |
TSS | chrX(+):279097 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_38265.1 | PLCXD1 | Chimeric | Non-coding | Non-coding | chrX(+):279098,279185,284167,284314,288733,288869,290648,290776,291499,291654,293035,293218,299097,299117 |
teRNA_38265.2 | PLCXD1 | Chimeric | Other | MGGQVSASNSFSRLHCRNANEDWMSALCPRLWDVPLHHLSIPGSHDTMTYCLNKKSPISHEESRLLQLLNKALPCITRPVVLKWSVTQALDVTEQLDAGVRYLDLRIAHMLEGSEKNLHFVHMVYTTALVEVRPG* | chrX(+):279098,279185,284167,284314,288733,288869,290648,290792,291499,291519 |
teRNA_38265.3 | PLCXD1 | Chimeric | Non-coding | Non-coding | chrX(+):279098,279185,284167,284314,288733,288869,290648,290776,291499,291519 |
teRNA_38265.4 | PLCXD1 | Chimeric | Non-coding | Non-coding | chrX(+):279098,279185,284167,284314,288733,288753 |
teRNA_38265.5 | PLCXD1 | Chimeric | Non-coding | Non-coding | chrX(+):279098,279185,281482,281684,284167,284314,288733,288869,290648,290776,291499,291654,293035,293218,299097,299117 |
teRNA_38265.6 | PLCXD1 | Chimeric | Non-coding | Non-coding | chrX(+):279098,279185,281482,281684,284167,284314,288733,288753 |
teRNA_38265.7 | PLCXD1 | Chimeric | Non-coding | Non-coding | chrX(+):279098,279185,279293,279439,281482,281684,284167,284314,288733,288869,290648,290776,291499,291654,293035,293218,299097,299117 |
teRNA_38265.8 | PLCXD1 | Chimeric | Non-coding | Non-coding | chrX(+):279098,279185,279293,279439,281482,281684,284167,284314,288733,288753 |
teRNA_38265.9 | PLCXD1 | Chimeric | Non-coding | Non-coding | chrX(+):279098,279185,281610,281684,284167,284314,288733,288869,290648,290776,291499,291654,293035,293218,299097,299117 |
teRNA_38265.10 | PLCXD1 | Chimeric | Non-coding | Non-coding | chrX(+):279098,279185,281610,281684,284167,284314,288733,288753 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.